← brief for 2026-08-26 · Slowing decline

Finerenone in type 1 diabetes and chronic kidney disease

Paper No results yet Peer reviewed

Key takeaways

This is a discussion piece about using finerenone, a drug that blocks a hormone signal that scars and inflames the kidney, in people who have type 1 diabetes along with kidney disease. Finerenone has good trial evidence in type 2 diabetes, but those trials did not include type 1, so its use there is an open question. This article argues the case and reviews what is known. It reports no new trial results.

Who did this work

Bertram Pitt · Christopher S. Wilcox (Georgetown University)

Source

Paper · OpenAlex, CKD works · 2026-08-25
https://doi.org/10.20517/mtod.2026.105